# 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes

> **NCT00993473** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 125 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin glargine (HOE901)
- **DRUG:** Neutral Protamine Hagedorn (NPH) insulin
- **DRUG:** Insulin lispro

## Key facts

- **NCT ID:** NCT00993473
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2012-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993473, "6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00993473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*